Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC)
1 clinical trials · Condition
◉ Watch Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC)
| Record | Firm | Date |
|---|---|---|
| NT-I7 in Combination With Nivolumab in Advanced Gastric, Gastro-Esophageal Junction or Esophageal Adenocarcinoma (NCT04594811) | NeoImmuneTech | 2021-01-21 |
Track Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC) automatically
Every clearance here is in the API, with alerts when new ones post.